Jacinda Nicklas
Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes, Gestational | 15 | 2025 | 307 | 3.820 |
Why?
| | Postpartum Period | 13 | 2025 | 377 | 2.540 |
Why?
| | Life Style | 13 | 2026 | 495 | 2.370 |
Why?
| | Metabolic Syndrome | 7 | 2026 | 364 | 1.690 |
Why?
| | Depression, Postpartum | 5 | 2025 | 116 | 1.560 |
Why?
| | Obesity | 12 | 2026 | 3123 | 1.340 |
Why?
| | Diabetes Mellitus, Type 2 | 10 | 2023 | 2623 | 1.110 |
Why?
| | Weight Loss | 7 | 2026 | 857 | 1.080 |
Why?
| | Menopause | 2 | 2026 | 327 | 0.930 |
Why?
| | Overweight | 6 | 2024 | 613 | 0.910 |
Why?
| | Feeding Behavior | 3 | 2026 | 691 | 0.900 |
Why?
| | Food Assistance | 2 | 2023 | 33 | 0.780 |
Why?
| | Cardiovascular Diseases | 6 | 2024 | 2218 | 0.760 |
Why?
| | Pregnancy | 24 | 2025 | 7217 | 0.730 |
Why?
| | Bariatric Surgery | 1 | 2026 | 248 | 0.730 |
Why?
| | Exercise | 6 | 2026 | 2206 | 0.720 |
Why?
| | Body Mass Index | 12 | 2026 | 2446 | 0.630 |
Why?
| | Health Promotion | 4 | 2023 | 786 | 0.610 |
Why?
| | Metformin | 4 | 2024 | 328 | 0.570 |
Why?
| | Healthy Lifestyle | 1 | 2019 | 38 | 0.570 |
Why?
| | Feasibility Studies | 1 | 2023 | 1125 | 0.550 |
Why?
| | Metabolic Diseases | 1 | 2019 | 114 | 0.530 |
Why?
| | Behavior Therapy | 2 | 2024 | 290 | 0.510 |
Why?
| | Patient Selection | 2 | 2024 | 720 | 0.500 |
Why?
| | Patient Discharge Summaries | 1 | 2017 | 10 | 0.500 |
Why?
| | Waist Circumference | 4 | 2026 | 142 | 0.490 |
Why?
| | Adult | 30 | 2026 | 40821 | 0.480 |
Why?
| | Female | 40 | 2026 | 79080 | 0.480 |
Why?
| | Medical Records | 1 | 2017 | 190 | 0.470 |
Why?
| | Delivery, Obstetric | 1 | 2017 | 164 | 0.450 |
Why?
| | Prenatal Diagnosis | 1 | 2017 | 190 | 0.440 |
Why?
| | Boston | 4 | 2025 | 90 | 0.420 |
Why?
| | Anti-Obesity Agents | 2 | 2026 | 67 | 0.410 |
Why?
| | Dietary Carbohydrates | 2 | 2024 | 145 | 0.410 |
Why?
| | Diet, Reducing | 1 | 2013 | 90 | 0.370 |
Why?
| | Appetite Depressants | 1 | 2012 | 19 | 0.360 |
Why?
| | Humans | 43 | 2026 | 145625 | 0.350 |
Why?
| | Dietary Proteins | 1 | 2013 | 135 | 0.350 |
Why?
| | Patient Transfer | 2 | 2025 | 223 | 0.340 |
Why?
| | Dietary Fats | 1 | 2013 | 307 | 0.330 |
Why?
| | Health Knowledge, Attitudes, Practice | 5 | 2024 | 1403 | 0.320 |
Why?
| | C-Reactive Protein | 1 | 2013 | 427 | 0.320 |
Why?
| | Health Behavior | 3 | 2025 | 801 | 0.290 |
Why?
| | Diet | 3 | 2025 | 1271 | 0.290 |
Why?
| | Ivermectin | 3 | 2024 | 15 | 0.290 |
Why?
| | Fluvoxamine | 3 | 2024 | 18 | 0.290 |
Why?
| | Middle Aged | 18 | 2026 | 36359 | 0.280 |
Why?
| | Follow-Up Studies | 3 | 2026 | 5397 | 0.260 |
Why?
| | Weight Gain | 3 | 2018 | 561 | 0.260 |
Why?
| | Antiviral Agents | 2 | 2024 | 774 | 0.240 |
Why?
| | Internet | 4 | 2023 | 656 | 0.240 |
Why?
| | Risk Factors | 10 | 2025 | 10840 | 0.230 |
Why?
| | Risk Reduction Behavior | 4 | 2026 | 219 | 0.220 |
Why?
| | Mothers | 2 | 2022 | 771 | 0.220 |
Why?
| | Premenopause | 1 | 2026 | 129 | 0.220 |
Why?
| | Habits | 1 | 2025 | 47 | 0.220 |
Why?
| | Perimenopause | 1 | 2026 | 69 | 0.220 |
Why?
| | Pre-Eclampsia | 2 | 2020 | 206 | 0.220 |
Why?
| | Pandemics | 2 | 2024 | 1700 | 0.220 |
Why?
| | Depression | 3 | 2024 | 1566 | 0.210 |
Why?
| | Snacks | 1 | 2024 | 23 | 0.210 |
Why?
| | Obesity Management | 1 | 2023 | 12 | 0.200 |
Why?
| | Appetite | 1 | 2024 | 80 | 0.200 |
Why?
| | Preconception Care | 1 | 2024 | 50 | 0.200 |
Why?
| | Live Birth | 1 | 2024 | 81 | 0.200 |
Why?
| | Postmenopause | 1 | 2026 | 394 | 0.200 |
Why?
| | Workload | 1 | 2025 | 169 | 0.190 |
Why?
| | Trust | 1 | 2025 | 160 | 0.190 |
Why?
| | Mass Screening | 2 | 2024 | 1300 | 0.190 |
Why?
| | Treatment Outcome | 6 | 2026 | 11744 | 0.190 |
Why?
| | Fertility | 1 | 2024 | 173 | 0.180 |
Why?
| | Blood Glucose | 5 | 2026 | 2357 | 0.180 |
Why?
| | Body Weight | 2 | 2019 | 964 | 0.180 |
Why?
| | Young Adult | 6 | 2024 | 14240 | 0.180 |
Why?
| | Viral Load | 1 | 2024 | 525 | 0.180 |
Why?
| | Perception | 1 | 2025 | 372 | 0.180 |
Why?
| | Health Equity | 1 | 2024 | 139 | 0.170 |
Why?
| | Cross-Over Studies | 1 | 2024 | 612 | 0.170 |
Why?
| | Internal Medicine | 1 | 2024 | 279 | 0.170 |
Why?
| | Qualitative Research | 3 | 2025 | 1720 | 0.170 |
Why?
| | Interviews as Topic | 4 | 2025 | 926 | 0.160 |
Why?
| | Self Report | 1 | 2025 | 869 | 0.160 |
Why?
| | Glucose Tolerance Test | 2 | 2023 | 360 | 0.160 |
Why?
| | Maternal Health Services | 1 | 2021 | 99 | 0.150 |
Why?
| | Male | 14 | 2026 | 73014 | 0.150 |
Why?
| | Poverty | 1 | 2023 | 530 | 0.140 |
Why?
| | Cardiovascular System | 1 | 2020 | 137 | 0.140 |
Why?
| | Sex Factors | 1 | 2024 | 2101 | 0.140 |
Why?
| | Racism | 1 | 2021 | 147 | 0.140 |
Why?
| | Insulin | 2 | 2024 | 2524 | 0.140 |
Why?
| | Obstetrics | 1 | 2020 | 178 | 0.140 |
Why?
| | Biomarkers | 2 | 2024 | 4329 | 0.140 |
Why?
| | Energy Metabolism | 1 | 2024 | 930 | 0.130 |
Why?
| | Healthcare Disparities | 1 | 2024 | 728 | 0.130 |
Why?
| | Pilot Projects | 1 | 2023 | 1878 | 0.130 |
Why?
| | Anti-Inflammatory Agents | 1 | 2021 | 473 | 0.130 |
Why?
| | Child Development | 1 | 2021 | 481 | 0.120 |
Why?
| | Aged | 8 | 2025 | 26251 | 0.120 |
Why?
| | Stress, Psychological | 1 | 2025 | 1169 | 0.120 |
Why?
| | Anxiety | 1 | 2024 | 1118 | 0.120 |
Why?
| | Focus Groups | 3 | 2015 | 587 | 0.110 |
Why?
| | Double-Blind Method | 3 | 2024 | 2064 | 0.100 |
Why?
| | Confidence Intervals | 1 | 2013 | 328 | 0.090 |
Why?
| | Preventive Health Services | 1 | 2014 | 154 | 0.090 |
Why?
| | Glucagon-Like Peptide 1 | 2 | 2024 | 150 | 0.090 |
Why?
| | Guideline Adherence | 1 | 2017 | 585 | 0.090 |
Why?
| | Infant | 2 | 2024 | 10093 | 0.090 |
Why?
| | Absorptiometry, Photon | 1 | 2013 | 276 | 0.090 |
Why?
| | Cesarean Section | 1 | 2013 | 229 | 0.090 |
Why?
| | Fasting | 1 | 2013 | 280 | 0.080 |
Why?
| | Retrospective Studies | 3 | 2021 | 17291 | 0.080 |
Why?
| | Cholesterol | 1 | 2013 | 410 | 0.080 |
Why?
| | Odds Ratio | 1 | 2013 | 1070 | 0.080 |
Why?
| | Indians, North American | 1 | 2015 | 527 | 0.080 |
Why?
| | Adolescent | 3 | 2019 | 22451 | 0.080 |
Why?
| | Program Evaluation | 1 | 2014 | 945 | 0.080 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2022 | 512 | 0.080 |
Why?
| | Prognosis | 1 | 2018 | 4331 | 0.070 |
Why?
| | Body Composition | 1 | 2013 | 686 | 0.070 |
Why?
| | Adipose Tissue | 1 | 2013 | 641 | 0.070 |
Why?
| | Adiposity | 1 | 2013 | 531 | 0.070 |
Why?
| | Glucose | 2 | 2023 | 1051 | 0.070 |
Why?
| | Blood Pressure | 2 | 2026 | 1761 | 0.070 |
Why?
| | Patient Acceptance of Health Care | 1 | 2015 | 880 | 0.070 |
Why?
| | Socioeconomic Factors | 1 | 2012 | 1323 | 0.060 |
Why?
| | Social Support | 1 | 2011 | 644 | 0.060 |
Why?
| | United States | 3 | 2025 | 16041 | 0.060 |
Why?
| | Remission Induction | 1 | 2026 | 308 | 0.050 |
Why?
| | Single-Blind Method | 1 | 2026 | 312 | 0.050 |
Why?
| | Peptide YY | 1 | 2024 | 28 | 0.050 |
Why?
| | Health Information Exchange | 1 | 2024 | 23 | 0.050 |
Why?
| | Gastric Balloon | 1 | 2023 | 17 | 0.050 |
Why?
| | Child | 1 | 2024 | 22638 | 0.050 |
Why?
| | Postprandial Period | 1 | 2024 | 114 | 0.050 |
Why?
| | Healthy Volunteers | 1 | 2024 | 217 | 0.050 |
Why?
| | Pregnancy Rate | 1 | 2024 | 83 | 0.050 |
Why?
| | Propiophenones | 1 | 2023 | 1 | 0.050 |
Why?
| | Fruit | 1 | 2024 | 144 | 0.050 |
Why?
| | Nitro Compounds | 1 | 2023 | 8 | 0.050 |
Why?
| | Vegetables | 1 | 2024 | 159 | 0.050 |
Why?
| | Abortion, Spontaneous | 1 | 2024 | 119 | 0.050 |
Why?
| | Infertility, Female | 1 | 2024 | 124 | 0.050 |
Why?
| | New Zealand | 1 | 2021 | 56 | 0.040 |
Why?
| | Academic Medical Centers | 1 | 2025 | 560 | 0.040 |
Why?
| | Patient Health Questionnaire | 1 | 2021 | 43 | 0.040 |
Why?
| | Eating | 1 | 2024 | 386 | 0.040 |
Why?
| | Energy Intake | 1 | 2024 | 506 | 0.040 |
Why?
| | Cohort Studies | 2 | 2022 | 6045 | 0.040 |
Why?
| | Reimbursement, Incentive | 1 | 2021 | 42 | 0.040 |
Why?
| | Parturition | 1 | 2021 | 72 | 0.040 |
Why?
| | Hospitalists | 1 | 2024 | 288 | 0.040 |
Why?
| | Outpatients | 1 | 2023 | 437 | 0.040 |
Why?
| | Triglycerides | 1 | 2021 | 527 | 0.040 |
Why?
| | Age Factors | 1 | 2026 | 3321 | 0.030 |
Why?
| | Peptides | 1 | 2023 | 991 | 0.030 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2022 | 437 | 0.030 |
Why?
| | Breast Feeding | 1 | 2021 | 447 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1754 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2021 | 782 | 0.030 |
Why?
| | Child, Preschool | 2 | 2022 | 11888 | 0.030 |
Why?
| | Incidence | 1 | 2023 | 2910 | 0.030 |
Why?
| | Health Services Accessibility | 1 | 2024 | 1101 | 0.030 |
Why?
| | Physicians | 1 | 2024 | 954 | 0.030 |
Why?
| | Oklahoma | 1 | 2015 | 21 | 0.030 |
Why?
| | Hypertension | 1 | 2023 | 1270 | 0.030 |
Why?
| | Hypoxia | 1 | 2022 | 1209 | 0.030 |
Why?
| | Prevalence | 1 | 2021 | 2852 | 0.030 |
Why?
| | Vaccination | 1 | 2023 | 1444 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2021 | 942 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2021 | 3005 | 0.030 |
Why?
| | Risk Assessment | 2 | 2013 | 3678 | 0.020 |
Why?
| | Food | 1 | 2013 | 149 | 0.020 |
Why?
| | Women's Health | 1 | 2015 | 317 | 0.020 |
Why?
| | Text Messaging | 1 | 2015 | 187 | 0.020 |
Why?
| | Family Characteristics | 1 | 2013 | 202 | 0.020 |
Why?
| | Patient Preference | 1 | 2013 | 224 | 0.020 |
Why?
| | Prospective Studies | 1 | 2023 | 8087 | 0.020 |
Why?
| | Hospitalization | 1 | 2021 | 2468 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2022 | 8351 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2015 | 5875 | 0.010 |
Why?
| | Time Factors | 1 | 2013 | 7079 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2015 | 6050 | 0.010 |
Why?
|
|
Nicklas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|